- Home
- DHT vs RLAY Comparison
DHT vs RLAY Comparison
Compare DHT & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DHT | RLAY |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | 2005 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DHT | RLAY |
|---|---|---|
| Price | $16.70 | $13.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $19.33 | ★ $19.50 |
| AVG Volume (30 Days) | 2.8M | ★ 4.3M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.36% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $8.85 | N/A |
| Revenue Next Year | N/A | $324.03 |
| P/E Ratio | $12.73 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $10.61 | $2.98 |
| 52 Week High | $20.55 | $17.47 |
Technical Indicators
Market Signals| Indicator | DHT | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 45.85 |
| Support Level | $12.59 | $11.68 |
| Resistance Level | $18.80 | $15.45 |
| Average True Range (ATR) | 0.55 | 1.24 |
| MACD | -0.11 | 0.06 |
| Stochastic Oscillator | 27.42 | 25.81 |
Price Performance
Historical ComparisonAbout DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.